142 related articles for article (PubMed ID: 25612487)
1. Advances in the understanding of complement mediated glomerular disease: implications for recurrence in the transplant setting.
Barbour S; Gill JS
Am J Transplant; 2015 Feb; 15(2):312-9. PubMed ID: 25612487
[TBL] [Abstract][Full Text] [Related]
2. Recurrence of immune complex and complement-mediated membranoproliferative glomerulonephritis in kidney transplantation.
Caravaca-Fontán F; Polanco N; Villacorta B; Buxeda A; Coca A; Ávila A; Martínez-Gallardo R; Galeano C; Valero R; Ramos N; Allende N; Cruzado-Vega L; Pérez-Sáez MJ; Sevillano Á; González E; Hernández A; Rodrigo E; Fernández-Ruiz M; Aguado JM; Pérez Valdivia MÁ; Pascuall J; Andrés A; Praga M;
Nephrol Dial Transplant; 2023 Jan; 38(1):222-235. PubMed ID: 35404425
[TBL] [Abstract][Full Text] [Related]
3. Membranoproliferative glomerulonephritis recurrence after kidney transplantation: using the new classification.
Alasfar S; Carter-Monroe N; Rosenberg AZ; Montgomery RA; Alachkar N
BMC Nephrol; 2016 Jan; 17():7. PubMed ID: 26754737
[TBL] [Abstract][Full Text] [Related]
4. Complete biopsy-proven resolution of deposits in recurrent proliferative glomerulonephritis with monoclonal IgG deposits (PGNMIGD) following rituximab treatment in renal allograft.
Von Visger J; Cassol C; Nori U; Franco-Ahumada G; Nadasdy T; Satoskar AA
BMC Nephrol; 2019 Feb; 20(1):53. PubMed ID: 30764798
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune abnormalities of the alternative complement pathway in membranoproliferative glomerulonephritis and C3 glomerulopathy.
Noris M; Donadelli R; Remuzzi G
Pediatr Nephrol; 2019 Aug; 34(8):1311-1323. PubMed ID: 29948306
[TBL] [Abstract][Full Text] [Related]
6. Understanding the complement-mediated glomerular diseases: focus on membranoproliferative glomerulonephritis and C3 glomerulopathies.
Lionaki S; Gakiopoulou H; Boletis JN
APMIS; 2016 Sep; 124(9):725-35. PubMed ID: 27356907
[TBL] [Abstract][Full Text] [Related]
7. Severity of primary MPGN, rather than MPGN type, determines renal survival and post-transplantation recurrence risk.
Little MA; Dupont P; Campbell E; Dorman A; Walshe JJ
Kidney Int; 2006 Feb; 69(3):504-11. PubMed ID: 16395262
[TBL] [Abstract][Full Text] [Related]
8. Kidney Transplantation in C3 Glomerulopathy: A Case Series.
Regunathan-Shenk R; Avasare RS; Ahn W; Canetta PA; Cohen DJ; Appel GB; Bomback AS
Am J Kidney Dis; 2019 Mar; 73(3):316-323. PubMed ID: 30413277
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcomes of patients with end-stage kidney disease due to membranoproliferative glomerulonephritis: an ANZDATA registry study.
Wilson GJ; Cho Y; Teixiera-Pinto A; Isbel N; Campbell S; Hawley C; Johnson DW
BMC Nephrol; 2019 Nov; 20(1):417. PubMed ID: 31752734
[TBL] [Abstract][Full Text] [Related]
10. Recurrent membranoproliferative glomerulonephritis after kidney transplantation.
Lorenz EC; Sethi S; Leung N; Dispenzieri A; Fervenza FC; Cosio FG
Kidney Int; 2010 Apr; 77(8):721-8. PubMed ID: 20130531
[TBL] [Abstract][Full Text] [Related]
11. A case report of recurrent membranoproliferative glomerulonephritis after kidney transplantation due to ventriculoatrial shunt infection.
Völker LA; Burkert K; Scholten N; Grundmann F; Kurschat C; Benzing T; Hampl J; Becker JU; Müller RU
BMC Nephrol; 2019 Aug; 20(1):296. PubMed ID: 31382904
[TBL] [Abstract][Full Text] [Related]
12. C3 glomerulopathy: what's in a name?
D'Agati VD; Bomback AS
Kidney Int; 2012 Aug; 82(4):379-81. PubMed ID: 22846813
[TBL] [Abstract][Full Text] [Related]
13. Immunohistological and ultrastructural differences between recurrent type I membranoproliferative glomerulonephritis and chronic transplant glomerulopathy.
Andresdottir MB; Assmann KJ; Koene RA; Wetzels JF
Am J Kidney Dis; 1998 Oct; 32(4):582-8. PubMed ID: 9774118
[TBL] [Abstract][Full Text] [Related]
14. Morphofunctional Effects of C5 Convertase Blockade in Immune Complex-Mediated Membranoproliferative Glomerulonephritis: Report of Two Cases with Evidence of Terminal Complement Activation.
Carrara C; Podestà MA; Abbate M; Rizzo P; Piras R; Alberti M; Daina E; Ruggenenti P; Remuzzi G;
Nephron; 2020; 144(4):195-203. PubMed ID: 32050203
[TBL] [Abstract][Full Text] [Related]
15. C5 Convertase Blockade in Membranoproliferative Glomerulonephritis: A Single-Arm Clinical Trial.
Ruggenenti P; Daina E; Gennarini A; Carrara C; Gamba S; Noris M; Rubis N; Peraro F; Gaspari F; Pasini A; Rigotti A; Lerchner RM; Santoro D; Pisani A; Pasi A; Remuzzi G;
Am J Kidney Dis; 2019 Aug; 74(2):224-238. PubMed ID: 30929851
[TBL] [Abstract][Full Text] [Related]
16. Recurrence of membranoproliferative glomerulonephritis type II in renal allografts: The North American Pediatric Renal Transplant Cooperative Study experience.
Braun MC; Stablein DM; Hamiwka LA; Bell L; Bartosh SM; Strife CF
J Am Soc Nephrol; 2005 Jul; 16(7):2225-33. PubMed ID: 15888559
[TBL] [Abstract][Full Text] [Related]
17. Pathology of renal diseases associated with dysfunction of the alternative pathway of complement: C3 glomerulopathy and atypical hemolytic uremic syndrome (aHUS).
Sethi S; Fervenza FC
Semin Thromb Hemost; 2014 Jun; 40(4):416-21. PubMed ID: 24799306
[TBL] [Abstract][Full Text] [Related]
18. Recurrent type I membranoproliferative glomerulonephritis after renal transplantation and protective role of cyclosporine in acute crescentic transformation.
Ahsan N; Manning EC; Dabbs DJ; Gifford RR; Yang HC
Clin Transplant; 1997 Feb; 11(1):9-14. PubMed ID: 9067687
[TBL] [Abstract][Full Text] [Related]
19. Histopathology of MPGN and C3 glomerulopathies.
Cook HT; Pickering MC
Nat Rev Nephrol; 2015 Jan; 11(1):14-22. PubMed ID: 25447133
[TBL] [Abstract][Full Text] [Related]
20. FHR-5 Serum Levels and
Garam N; Cserhalmi M; Prohászka Z; Szilágyi Á; Veszeli N; Szabó E; Uzonyi B; Iliás A; Aigner C; Schmidt A; Gaggl M; Sunder-Plassmann G; Bajcsi D; Brunner J; Dumfarth A; Cejka D; Flaschberger S; Flögelova H; Haris Á; Hartmann Á; Heilos A; Mueller T; Rusai K; Arbeiter K; Hofer J; Jakab D; Sinkó M; Szigeti E; Bereczki C; Janko V; Kelen K; Reusz GS; Szabó AJ; Klenk N; Kóbor K; Kojc N; Knechtelsdorfer M; Laganovic M; Lungu AC; Meglic A; Rus R; Kersnik Levart T; Macioniene E; Miglinas M; Pawłowska A; Stompór T; Podracka L; Rudnicki M; Mayer G; Rysava R; Reiterova J; Saraga M; Seeman T; Zieg J; Sládková E; Stajic N; Szabó T; Capitanescu A; Stancu S; Tisljar M; Galesic K; Tislér A; Vainumäe I; Windpessl M; Zaoral T; Zlatanova G; Józsi M; Csuka D
Front Immunol; 2021; 12():720183. PubMed ID: 34566977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
